Analystreport

Conatus Pharmaceuticals Inc (NASDAQ: CNAT) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating.

CONATUS PHARMACEUTICALS INC  (CNAT) 
Last conatus pharmaceuticals inc earnings: 11/5 04:05 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.conatuspharma.com/investor-relations